Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER
The benefit in those with less atherosclerosis emerged late, highlighting the long-term benefits of LDL lowering.
The benefit in those with less atherosclerosis emerged late, highlighting the long-term benefits of LDL lowering.
Identification of hospitalized patients with suddenly unfavorable clinical course remains challenging. Models using objective data elements from the electronic health record may miss important sources…
Dispositivo diseñado para monitorear la actividad cardíaca de manera rápida y precisa. Útil para detectar arritmias al ayudar a identificar y registrar episodios de ritmos…
ULTIMATE-DAPT seemed to indicate the safety and efficacy of this strategy, but it hasn’t seemed to shift practice, yet.
On average, 15-20% of patients who have a TAVR aortic valve procedure end up needing a pacemaker as well. Here’s an explanation why, in plain…
Interventionalists say it’s now time to make a dent in the complication rate, whether by strict protocols or smaller devices.
Preventive Cardiologist writing on how to prevent heart disease and live longer. Click to read Dr Paddy Barrett, a Substack publication.
Even at a mean age of 85 years, there is still time to accrue mortality benefits from potent LDL-lowering therapies.
Recent guidelines recommend that patients with heart failure and left ventricular ejection fraction (LVEF) 40–49% should be managed similar to LVEF ≥ 50%. We investigated the effect…
Quality-led, patient-centered education for early-career physicians and experienced practitioners. Events Presenting a multi-device approach to complex revascularization in patients with complex coronary arterial disease. ……
Doors open 7pm, show starts 7.30pm The worse the political career, the more lucrative the subsequent entertainment opportunities. Matt Hancock may have slaughtered millions but…